People Biography

السيرة الذاتية

Dr. Vaikath has a PhD in medical science from Lund University, Sweden, specializing in neuroscience within the faculty of medicine. Prior to that, he gained five years of experience in India's biotech industry. During this period, his work focused on the expression and purification of recombinant proteins linked to diseases such as HIV and HCV for diagnostic applications. He then transitioned to the antibody development team, eventually leading a group dedicated to monoclonal and polyclonal antibody development targeting various peptides and proteins associated with cancer, diabetes, and neurological disorders.

Following his industry tenure, he joined the College of Medicine and Health Sciences at United Arab Emirates University. There, his focus shifted to generating and characterizing monoclonal and polyclonal antibodies against proteins implicated in neurological disorders such as Alzheimer’s and Parkinson’s disease.

In 2016, he joined Qatar Biomedical Research Institute as a research associate. His work concentrated on designing conformation-specific antibodies to address alpha-synuclein pathology, advancing therapeutic and diagnostic approaches in synucleinopathies. Additionally, he has contributed to the development and characterization of nanobodies tailored to combat diverse pathogenic protein variants in neurodegenerative diseases. Currently, he serves as a senior research associate. His focus remains on antibody and nanobody engineering, emphasizing enhanced delivery across biological barriers, notably the blood-brain barrier.